Ares Capital Corp. research and ratings by Barron's. View ARCC revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Year to date through September 2025, the FDA’s list of AI-enabled device authorizations included more than 250 devices, with Radiology taking the lead.
TipRanks on MSN
CareDx price target raised to $18 from $14 at Wells Fargo
Wells Fargo analyst Brandon Couillard raised the firm’s price target on CareDx (CDNA) to $18 from $14 and keeps an Equal Weight rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback